GWM
CTVA icon

Geneos Wealth Management’s Corteva CTVA Stock Holding History

Geneos Wealth Management’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$345K Buy
4,127
+225
+6% +$16.9K 0.01% 799
2025
Q4 		$262K Sell
3,902
-292
-7% -$18.9K 0.01% 845
2025
Q3 		$284K Sell
4,194
-1,136
-21% -$82.3K 0.01% 802
2025
Q2 		$397K Sell
5,330
-2,168
-29% -$144K 0.01% 778
2025
Q1 		$591K Buy
7,498
+4,187
+126% +$259K 0.01% 830
2024
Q4 		$189K Buy
3,311
+281
+9% +$16.6K 0.01% 865
2024
Q3 		$178K Buy
3,030
+1,002
+49% +$54.7K 0.01% 804
2024
Q2 		$109K Buy
2,028
+16
+0.8% +$881 ﹤0.01% 844
2024
Q1 		$116K Sell
2,012
-79
-4% -$4.08K 0.01% 816
2023
Q4 		$100K Sell
2,091
-1,485
-42% -$70.8K ﹤0.01% 838
2023
Q3 		$183K Buy
3,576
+168
+5% +$8.9K 0.01% 706
2023
Q2 		$195K Sell
3,408
-294
-8% -$17.2K 0.01% 691
2023
Q1 		$223K Sell
3,702
-211
-5% -$12.9K 0.01% 627
2022
Q4 		$230K Sell
3,913
-128
-3% -$8.1K 0.01% 598
2022
Q3 		$230K Sell
4,041
-2,919
-42% -$170K 0.02% 562
2022
Q2 		$376K Sell
6,960
-575
-8% -$33.4K 0.02% 575
2022
Q1 		$433K Buy
7,535
+272
+4% +$13.9K 0.02% 571
2021
Q4 		$343K Sell
7,263
-1,180
-14% -$53.7K 0.01% 692
2021
Q3 		$367K Sell
8,443
-666
-7% -$28.8K 0.01% 658
2021
Q2 		$405K Sell
9,109
-6,509
-42% -$301K 0.02% 617
2021
Q1 		$761K Buy
15,618
+48
+0.3% +$2.12K 0.02% 513
2020
Q4 		$428K Buy
15,570
+7,016
+82% +$251K 0.02% 580
2020
Q3 		$242K Sell
8,554
-1,277
-13% -$36K 0.01% 624
2020
Q2 		$254K Buy
9,831
+290
+3% +$7.55K 0.01% 593
2020
Q1 		$221K Sell
9,541
-1,212
-11% -$33.3K 0.01% 583
2019
Q4 		$313K Sell
10,753
-1,391
-11% -$36.8K 0.02% 548
2019
Q3 		$337K Sell
12,144
-2,074
-15% -$60K 0.02% 501
2019
Q2 		$420K Buy
+14,218
New +$383K 0.03% 459

Other funds holding CTVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geneos Wealth Management's CTVA Position: Q1 2026 in Review

Geneos Wealth Management increased its Corteva (CTVA) stake by 5.8% in Q1 2026, buying an estimated $16.9K and bringing the position to 4,127 shares worth $345K. The position accounts for 0.01% of the portfolio, ranked #799.

Geneos Wealth Management first reported a position in CTVA in Q2 2019 and has held it in 28 quarters since. The position peaked at $761K in Q1 2021. 1,476 funds tracked by Wall St. Rank hold CTVA as of Q1 2026.

  • Geneos Wealth Management held 4,127 shares of Corteva worth $345K as of Q1 2026.
  • Geneos Wealth Management bought 225 Corteva shares in Q1 2026, an estimated $16.9K.
  • Corteva made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #799 holding.
  • Geneos Wealth Management first reported a position in Corteva in Q2 2019 and has held it in 28 quarters since.
  • Geneos Wealth Management's Corteva position peaked at $761K in Q1 2021.
  • 1,476 funds tracked by Wall St. Rank held Corteva as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.